Biotech companies have been experiencing significant layoffs, with some firms reducing their workforce by as much as 70%. The industry has seen a rise in layoffs, with some outlets reporting increases of 57% and 87% in certain periods. The layoffs appear to be part of efforts to streamline operations and cut costs, with some companies also shifting focus or responding to setbacks in research and development.